![]() |
|
|
Vol. 284, Issue 1, 399-405, 1998
Department of Pharmacology and Cardiovascular Research Institute Maastricht (CARIM), Universiteit Maastricht, Maastricht, The Netherlands
| |
Abstract |
|---|
|
|
|---|
We evaluated the relationship between the presence of adrenergic nerves and the presence of alpha-1 adrenoceptors (alpha-1 AR) in the arterial tree of the rat. The thoracic aorta and the carotid, mammary, renal and femoral arteries were isolated from 20-week-old male WKY rats, along with the superior mesenteric artery and small (first order) and resistance-sized (third order) side branches of this vessel. Norepinephrine content ([NE]) and specific binding of 300 pM [3H]prazosin were determined. To estimate the total density of alpha-1 AR ([alpha-1 AR]) as well as the density of alpha-1A AR ([alpha-1A AR]), binding experiments were performed with and without pretreatment of the preparations with the irreversible alpha-1B AR and alpha-1D AR antagonist chloroethylclonidine and in the absence and presence of the alpha-1A AR selective ligand (+)-niguldipine (30 nM). Also the presence of mRNA for alpha-1A AR was evaluated by use of reverse transcriptase-polymerase chain reaction (RT-PCR). In intact rats, arterial [NE] ranged between 0.1 and 15 ng/µg DNA, arterial [alpha-1 AR] ranged between 12.4 and 46.8 fmol/mg protein and [alpha-1A AR] ranged between 0.05 and 27.9 fmol/mg protein. There was no significant correlation between [alpha-1 AR] and [NE]. However, with respect to the [alpha-1A AR] a significant correlation between [NE] and [alpha-1A AR] was observed. RT-PCR analysis confirmed the expression of alpha-1A AR in the densely innervated mesenteric resistance-sized arteries. Two weeks after chemical sympathectomy of the rats with 6-hydroxydopamine (i) arterial [NE] was markedly reduced, and (ii) a distinct reduction in the [alpha-1A AR] as percentage of the total [alpha-1 AR] density in mesenteric artery side branches was noted. These findings indicate that there is a positive and reversible relationship between the presence of adrenergic nerves and that of alpha-1A AR in rat arteries.
| |
Introduction |
|---|
|
|
|---|
Although
sympathetic nerves are heterogeneously distributed along the vascular
system (Bevan et al., 1980
; Nilsson, 1984
; Nilsson et
al., 1986
), exogenously supplied catecholamines constrict most
peripheral blood vessels. In arterial vessels of the rat, except for
the smaller arterioles (Faber, 1988
; Ohyanagi et al., 1991
),
these adrenergic vasoconstrictor responses are primarily mediated by
alpha-1 ARs (Vargas and Gorman, 1995
). Arterial
alpha-1 adrenergic vasoconstrictor responses can differ in
many respects depending on the anatomical location of the vessel. For
instance, in the poorly innervated rat aorta, contractile responses to
alpha-1 adrenergic agonists resist inhibition by the
alkylating agent phenoxybenzamine, removal of extracellular calcium,
dihydropyridine calcium antagonists and pertussis toxin (Bognar and
Enero, 1988
; Trabizchi, 1994
), whereas in the densely innervated rat
mesenteric resistance arteries these interventions readily inhibit
alpha-1 adrenergic responses (Boonen and De Mey, 1990a
, b
).
Besides differences in receptor density, differences regarding the
distribution of subtypes of alpha-1 AR may contribute to
this heterogeneity. We hypothesized that this may be related to
regional differences in periarterial innervation density.
Three subtypes of alpha-1 AR have been identified which
share a comparably high affinity for prazosin and which are
collectively referred to as alpha-1H AR (Bylund et
al., 1994
). The alpha-1A AR, alpha-1B AR and
alpha-1D AR subtypes differ in their amino acid sequence, in
their affinity for a growing list of synthetic ligands and with respect
to irreversible blockade by certain alkylating agents (Bylund et
al., 1994
; Graham et al., 1996
). They were reported to
be heterogeneously distributed along the rat arterial tree (Piascik
et al., 1994
). The functional significance of this remains unclear because the affinity of alpha-1H AR subtypes for
endogenous agonists does not differ (Ford et al., 1994
) and
because transfection studies indicated that each subtype can stimulate
calcium influx and phospholipase activities (Esbenshade and Minneman,
1995
). It was proposed that alpha-1H AR subtypes may differ
primarily in terms of the mechanisms that govern their chronic control
(Li et al., 1995
; Rokosh et al., 1996
). We
hypothesized that these include long-term influences of sympathetic
nerves. In this study we focused on the alpha-1A AR in rat
arteries and evaluated whether the presence of this subtype is related
to the presence of adrenergic nerves. To this end we determined the
binding of [3H]prazosin and effects of the
alpha-1A AR selective ligand (+)-niguldipine and the
irreversible alpha-1B AR and alpha-1D AR
antagonist CEC in eight types of rat artery that differ in terms of
adrenergic nerve density. Also the presence of alpha-1A AR
mRNA was evaluated in densely and poorly innervated rat arteries with
the use of the RT-PCR technique. The arterial preparations included the
thoracic aorta and some of its major side branches, three branching
orders of mesenteric arteries and the mammary artery (a small muscular vessel with only sparse adrenergic innervation). To evaluate the influence of adrenergic nerves on the presence of the
alpha-1A AR we repeated the experiments after chemical
sympathectomy of the rats with 6-hydroxydopamine (Aprigliano and
Hermsmeyer, 1977
).
| |
Material and Methods |
|---|
|
|
|---|
Reagents. [7-methoxy-3H]Prazosin hydrochloride (79.2 Ci/mmol) was purchased from New England Nuclear ('s Hertogenbosch, the Netherlands). Phentolamine mesylate was obtained from Ciba Geigy (Basel, Switzerland), CEC from Research Biochemicals International (Natick, MA), and 6-hydroxydopamine hydrochloride, bovine serum albumin and calf thymus DNA from Sigma Chemical Co. (Saint Louis, MO). (+)-Niguldipine was a generous gift from Byk Gulden (Konstanz, FRG). All other reagents, which were of analytical grade, were obtained from Sigma or Merck (Darmstadt, FRG). All drug stock solutions were freshly prepared daily in bidistilled water except for (+)-niguldipine which was prepared at 0.01 M in dimethyl sulfoxide, diluted to 1 mM in ethanol and further diluted in water and for 6-hydroxydopamine which was dissolved in sterile saline at pH 4.7. Murine molony leukemia virus reverse transcriptase was obtained from Life Technologies (Gaithersburg, MD), random hexanucleotide primers from Promega (Leiden, the Netherlands) and dNTPs from Pharmacia (Uppsala, Sweden). AmpliTaq DNA polymerase was purchased from Perkin and Elmer (Norwalk, CT).
Animals.
Twenty-week-old (n = 24) male
inbred Wistar Kyoto rats (Central Animal Facility, Universiteit
Maastricht, Maastricht, the Netherlands) were used. They were
maintained on a 12-hr light/12-hr dark cycle and had free access to
standard rat chow (Hope Farms, Woerden, The Netherlands) and drinking
water. The experimental procedures were performed according to
institutional guidelines and approved by the Ethics Committee for the
Use of Experimental Animals (Universiteit Maastricht). Some of the rats
(n = 12) were chemically sympathectomised with
6-hydroxydopamine (Aprigliano and Hermsmeyer, 1977
). They received two
i.p. injections of 50 mg/kg of the sympatholytic agent at 3-hr
intervals. This was repeated 7 days later, and the animals were used 14 days after the first injection.
Tissue preparation.
Rats were sacrificed by cervical
dislocation and exsanguination. The thoracic aorta, carotid arteries,
mammary arteries, superior mesenteric artery, renal arteries, femoral
arteries and the mesentery were isolated and collected in KRB
(composition in mM: NaCl, 118.5; KCl, 4.7; MgSO4 · 7H2O, 1.2; KH2PO4, 1.2;
NaHCO3, 25.0; CaCl2, 2.5; glucose, 5.5) at room
temperature and aerated with 5% CO2 in oxygen. Adhering
fat and connective tissue were removed by dissection from the large
vessels, and segments approximately 3 mm in length were prepared. The
adventitia was stripped off with fine watchmaker's forceps from the
aortic preparations. The mesentery was pinned out in a dish coated with
Sylgard (Dow Chemicals, Seneffe, Belgium) and filled with KRB. Fat and
mesenteric veins were carefully removed and 5- to 10-mm-long segments
were prepared from mesenteric small (first order side branch) and
resistance-sized (third order side branch) artery. The segments of the
eight types of artery were preincubated for 60 min in aerated KRB at
37°C. Part of the preparations were incubated for 30 min in 1 ml KRB containing 100 µM CEC and were then rinsed five times with 20 ml
drug-free KRB. This treatment has been reported to result in irreversible blockade of alpha-1B AR and alpha-1D
AR with little effect on alpha-1A AR (Michel et
al., 1990
).
Catecholamine content.
Tissue NE content was measured as an
indicator of the density of adrenergic nerves. Arterial segments were
placed in 1 ml of 0.1 N HCl containing 3 g/l glutathione for 1 week,
and the catecholamine content of the extract was determined by
high-performance liquid chromatography and fluorescent detection (van
der Hoorn et al., 1989
). In preliminary experiments with
mesenteric small arteries it was established that at least 48 hr were
needed to extract all catecholamines and that these remained stable in
the extract for at least 10 days. Unlike NE, the arterial contents of
epinephrine and dopamine were below the detection limits. After extraction the preparations were solubilized in 1 ml of 1 N NaOH to
determine their DNA content (Labarca and Paigen, 1980
).
Ligand binding.
Analysis of [3H]prazosin
binding was performed essentially as described by Michel et
al. (1993)
, but with use of intact arterial segments (Morel and
Godfraind, 1989
) instead of microsomes (Stassen et al.,
1997
). For saturation binding experiments, preparations were incubated
for 60 min at 37°C in 250 µl of 50 mM Tris-HCl, 5 mM
MgCl2 (pH 7.4) (incubation buffer) containing 30 to 800 pM [3H]prazosin. Nonspecific binding was determined in
parallel incubations in the continuous presence of phentolamine (25 µM). After incubation the arterial segments were gently blotted and
rinsed during vortexing for 30 sec with 1 ml incubation buffer at
37°C to remove ligand trapped in the lumen of the arterial segments.
They were then filtered over Whatman filters (GF/C) 5 times with 5 ml
ice-cold incubation buffer. Arterial segments were recovered from the
filters and solubilized in 200 µl of 1 N NaOH. Five milliliters of
scintillation solution (Formula 989, Packard, Groningen, The
Netherlands) was added to 100 µl of this preparation, and the
radioactivity was determined in a liquid scintillation counter
(Beckman, Fullerton, CA). To the remaining 100 µl, 900 µl
H2O was added and the protein content was determined as
described by Bradford (1976)
, with bovine serum albumin as internal
standard. Specific binding was calculated by subtracting nonspecific
binding from total binding and for each individual experiment was
analyzed in terms of density (Bmax) and affinity
(KD) by Scatchard analysis (Graphpad Inplot, San Diego, CA). With respect to the Scatchard analysis, 5 to 7 data points
were included for the thoracic aorta and 5 to 6 data points for
mesenteric small arteries.
Determination of alpha-1A AR mRNA expression in
mesenteric resistance arteries and thoracic aorta.
Animals were
anesthetized with ether and the thoracic aorta and the mesentery were
rapidly removed and placed on ice-cold KRB. Connective tissue and
adhering fat were removed from the aorta, whereas resistance-sized
arteries were isolated from the mesentery. Both types of artery were
then snap-frozen in liquid nitrogen and stored at
70°C until
further processing. Total RNA was isolated with slight modifications of
a method described previously (Auffray and Rougeon, 1980
). Arterial
segments (aorta, 10 mm; mesenteric resistance arteries, 20-30 mm) were
homogenised in ice-cold 3 M LiCl/6 M urea solution (containing 0.1%
sodium dodecyl sulfate and 0.3 volume of 2 M NaAc) by an Omni 2000 tissue homogenizer (Omni International, Waterbury, CT). After
incubation for 16 hr at 4°C, RNA was pelleted by centrifugation (25 min, 14,000 × g, 4°C). The pellet was then dissolved
in an ice-cold 4 M LiCl/8 M urea solution and centrifuged again (two
times). After the third centrifugation, the pellet was dissolved in a
1% sodium dodecyl sulfate solution (500 µl containing 2.5 volumes of
2 M NaAc). After extracting the RNA solution with phenol (45 min), the
RNA was precipitated for 16 hr with 3 M NaAc (0.1 volume) and ice-cold 100% ethanol (2 volumes). After centrifugation (14,000 × g, 25 min, 4°C) the pellet was washed with 70% ethanol,
centrifuged again and the resulting pellet dissolved in 15 µl
H2O. The integrity of the RNA was checked by gel
electrophoresis, whereas the total RNA content of each sample was
determined by densitometric scanning of the 18 S band and comparing the
signal with a RNA standard of 300 ng/µl. Between 0.75 and 1.5 µg of
total RNA were isolated per mesenteric resistance artery segment,
whereas aortic segments yielded 2 to 3 µg of total RNA.
-TGTCCCTGCAGAAGGCGG-3
(720-739); antisense,
5
-CTCACCCGGGCTGTGGTA-3
(1257-1274)] resulting in a PCR product
of 554 bp. The following amplification profile was used: 1
, 94°C;
2
, 65°C; 3
, 72°C; 30 cycles, 0.6 mM MgCl2. The
identity of the PCR product was verified by restriction analysis
(XbaI). To determine whether the absence of a positive
signal was caused by degradation of RNA we also determined the
expression of SM
-actin by PCR with cDNA derived from the same total
RNA sample as for the alpha-1A AR as a positive control. Ten
nanograms of total RNA were reversely transcribed as described above,
and the resulting cDNA was amplified by PCR with the following primers:
5
-TGTTTTCCCATCCATCGTG-3
(sense, 135-153) and
5
-ATGGCAGGGACATTGAAGGT-3
(antisense, 424-443). The following
amplification profile was used: 1
, 94°C; 1
, 56°C; 1.5
, 72°C;
29 cycles, 2.5 mM MgCl2. This resulted in a PCR product of
309 bp. To exclude the possibility that the resulting product was
obtained by amplification of genomic DNA, controls were performed without the addition of the reverse transcriptase.
Statistics.
Findings are shown as mean ± S.E.M.
Comparisons between types of vessel and analyses of the statistical
significance of drug effects were performed by analysis of variance
followed by Bonferroni's test for multiple comparisons (Wallenstein
et al., 1980
). P < .05 was considered to denote
statistically significance.
| |
Results |
|---|
|
|
|---|
Intact rats.
Table 1 summarizes
NE content in eight types of artery of 20-week-old WKY rats. This index
of adrenergic nerve density differed by 2 orders of magnitude between
large elastic conduit arteries such as the thoracic aorta and carotid
arteries (
0.1 ng NE/µgDNA) and small and resistance-sized
mesenteric artery side branches (
10-25 ng NE/µgDNA). Intermediate
innervation density (1-3 ng NE/µgDNA) was noted in muscular arteries
such as the superior mesenteric, renal and femoral artery (table 1).
The mammary artery, which is similar in size to the first order
mesenteric artery side branches (lumen diameter,
400 µm),
contained only 0.29 ± 0.02 ng NE/µgDNA. These marked regional
differences in adrenergic nerve density were confirmed by glyoxylic
acid-induced histofluorescence (Lindvall and Bjorklund, 1974
) (not
shown).
|
|
|
|
|
-actin (lane 2) and the
alpha-1A AR (lane 3) with use of RT-PCR with total RNA from
the thoracic aorta. Although a PCR product of the predicted size was
found for SM
-actin, no signal could be detected for the
alpha-1A AR. Figure 3B shows a similar experiment with total
RNA extracted from mesenteric resistance arteries. PCR products were
detected for both SM
-actin and the alpha-1A AR. No
products were detected when reverse transcriptase was omitted (lanes
1). These findings support our results obtained with the ligand binding
technique and indicate that the alpha-1A AR is expressed to
a considerably larger extent in densely innervated rat mesenteric
arteries than in the thoracic aorta.
|
Sympathectomized rats.
Chemical sympathectomy of 20-week-old
WKY with 6-hydroxydopamine did not significantly modify the NE content
in aorta, carotid and superior mesenteric arteries but reduced it by
more than 75% in the other vessels (table 1). In both aorta and
mesenteric artery side branches the density and affinity of
[3H]prazosin binding was not significantly modified after
chemical sympathectomy (table 2). Specific binding observed in the
presence of 300 pM [3H]prazosin (normalized to the
protein content of the preparations) was not significantly altered in
the aorta and carotid artery but was reduced by approximately 30 to
50% in the femoral artery, superior mesenteric artery and mesenteric
small arteries of sympathectomized rats (table 3). In large conduit and
muscular arteries, the pharmacological properties of these binding
sites were not modified. They were still blocked to a large extent by
CEC and little affected by (+)-niguldipine (table 3). In small
mesenteric artery side branches of sympathectomized rats, prazosin
binding was now, in contrast to findings in intact rats, also
profoundly reduced by CEC (intact,
40.4%; sympathectomized,
76.8%). (+)-Niguldipine, on the other hand, exhibited less effect
than in small mesenteric vessels from the intact rats (intact,
76.8%; sympathectomized,
35.6%).
| |
Discussion |
|---|
|
|
|---|
We evaluated the relationship between perivascular adrenergic
nerve density and the density and nature of prazosin binding sites in
intact arterial segments. Only subnanomolar concentrations of prazosin
were used to avoid interferences of alpha-2 AR (Bylund et al., 1994
). Consequently, the analysis was limited to
alpha-1 AR exhibiting a high affinity for the ligand
(alpha-1H AR), although arterial responses to
alpha-1 agonists may also involve subtypes of
alpha-1 AR that exhibit a low affinity for prazosin
(Muramatsu et al., 1990
). These alpha-1L AR,
which are poorly documented, were not addressed in the present study.
Because prazosin has been found not to modify NE release directly in
isolated smooth muscle preparations, alpha-1H AR may be
assumed to be located exclusively postjunctionally in rat arteries. Prolonged exposure of alpha-1 AR to agonists or antagonists,
especially at 37°C, may result in internalization and sequestration
of the receptors (Leeb-Lundberg et al., 1987
; Cowlen and
Toews, 1988
). Because both prazosin and phentolamine have been claimed
to be lipophilic (Cowlen and Toews, 1988
), the specific binding sites which we measured can represent both membrane-bound and intracellular receptors and give an adequate indication of the actual cellular alpha-1 AR density. The dissociation constant of
[3H]prazosin was similar in a large conduit vessel and
small mesenteric arteries. It was similar to what has been reported for
rat cerebral, cardiac and renal microsomes (Hanft and Gross, 1989
;
Hanft et al., 1989
; Jackson et al., 1992
) and for
the cloned subtypes of alpha-1H AR (Michel and Insel, 1994
).
Alpha-1A AR, alpha-1B AR and alpha-1D
AR have previously been found to exhibit identical affinity for
prazosin (Hanft and Gross, 1989
; Noguchi et al., 1993
; Ford
et al., 1994
). This justifies the use of a single
concentration of the ligand to compare alpha-1H AR density
between tissues. Clearly a full saturation binding analysis is
preferred, but the small size of some of the arteries that were
included in the present study forced us to adopt this approach.
We confirmed that rat arteries differ considerably in adrenergic nerve
density (Bevan et al., 1980
; Nilsson, 1984
; Nilsson et
al., 1986
). There does not seem to be a general pattern in this
respect. Like the thoracic aorta, the carotid artery contained very
little adrenergic neurotransmitter whereas other branches of the aorta
such as the superior mesenteric, renal and femoral artery contained 20 times more NE. In the mesenteric arterial bed, abrupt changes in
adrenergic nerve density were noted with branching. A marked increase
in innervation density from the superior mesenteric artery to its
first-order side branches is evident from both catecholamine content
(table 1) and histochemistry (not shown). However, we also identified a
small type of artery, the rat mammary artery, with very little
innervation. Thus, size alone does not seem to determine perivascular
innervation density. Differences in the production of nerve growth
factor during development have been proposed to be responsible for
regional differences in arterial innervation density in the adult
(Falckh et al., 1992a
, b
).
Despite a marked difference in innervation density between rat thoracic
aorta and mesenteric small arteries (150-fold), there was only a 2-fold
difference in alpha-1 AR Bmax values,
with the densely innervated vessel exhibiting the highest receptor
density. Also when comparing eight types of rat artery, the density of sites labeled by 300 pM prazosin differed much less than the
periarterial nerve density. Moreover, differences in
alpha-1H AR density between densely innervated arteries,
such as the mesenteric artery side branches, were in the same order of
magnitude as between densely and sparsely innervated arteries.
Furthermore, no significant correlation could be found between
alpha-1H AR density and arterial NE content.
Alpha-1H AR consist of three subtypes, however (Hieble et al., 1995
; Graham et al., 1996
) and we used
pharmacological tools to evaluate whether any of these could be closely
related to the innervation. Because earlier observations indicated the presence of alpha-1A AR in densely innervated arterial
systems such as the rat tail artery, renal and mesenteric vascular beds (Piascik et al., 1991
; Blue et al., 1992
; Kong
et al., 1994
; Williams and Clarke, 1995
), we concentrated on
this subtype. In aorta and carotid artery, an alpha-1A AR
selective concentration of (+)-niguldipine did not significantly modify
the specific [3H]prazosin binding, but the irreversible
alpha-1B AR and alpha-1D AR antagonist CEC
prevented all specific binding. In the densely innervated mesenteric
artery branches (+)-niguldipine had a marked inhibitory effect, and a
substantial fraction of the specific [3H]prazosin binding
persisted after exposure to CEC. Intermediate findings were obtained in
arteries with an innervation density ranging between that of the large
elastic vessels and the densely innervated mesenteric arteries.
Furthermore, a positive correlation was found between the
alpha-1A AR density and adrenergic innervation. These
findings indicate that the alpha-1A AR subtype predominates in arteries with a very high density of nerves, whereas in arteries with a low or intermediate innervation the alpha-1B AR
and/or the alpha-1D AR seem to be the major subtype(s). We
hypothesize that a high neurogenic input is required to induce and
maintain the expression of the alpha-1A AR.
Comparison of eight types of rat artery suggests that in the rat
arterial system alpha-1A AR predominates in vessels with a
high innervation density. Presence of mRNA for this subtype in the
mesenteric resistance-sized vessels and the virtual absence in the
thoracic aorta supports the hypothesis that the expression of the
alpha-1A AR subtype depends on a dense adrenergic
innervation. Additional support was obtained in arteries of rats that
had been chemically sympathectomized. After treatment with
6-hydroxydopamine, evaluation of the KD in aorta
and mesenteric small arteries did not reveal a significant modification
of affinity for prazosin. No significant changes in binding of 300 pM
[3H]prazosin were noted in aorta and carotid artery after
sympathectomy, which is in line with these vessels being not or only
sparsely innervated. In the other more densely innervated vessels
binding of 300 pM [3H]prazosin was significantly reduced.
After denervation, CEC blunted prazosin binding not only in large,
poorly innervated arteries but also in mesenteric small arteries.
Furthermore, (+)-niguldipine reduced binding in these vessels less
markedly after sympathectomy than before. Altogether, these findings
confirm that there is a positive relationship between the presence of
adrenergic nerves and that of alpha-1A AR in rat arteries.
They also suggest that this relationship is dynamic in nature because
removal of the nerves was accompanied by a replacement of this receptor
subtype by other alpha-1 AR subtype(s) (i.e.,
alpha-1B or alpha-1D AR). This is in line with
observations by Hanft and Gross (1990)
; they demonstrated that
reserpine treatment increased the proportion of alpha-1B ARs
in rat cerebral cortex by decreasing the NE concentration in brain
tissue. Desipramine, on the other hand, by inhibiting the neuronal
uptake and thereby increasing the availability of the neurotransmitter,
increased the 5-methylurapidil (an alpha-1A subtype
selective tool) sensitive part of [3H]prazosin binding.
This indicates that the tissue alpha-1 AR subtype
composition is dynamic in nature and depends on the adrenergic input.
The nature of the signal that may link adrenergic nerves to the
presence of alpha-1A AR on the arterial smooth muscle cells was not addressed in the present study. Besides NE itself, also sympathetic cotransmitters such as NPY and ATP (Burnstock, 1990
) deserve future attention. Although sympathetic nerves may exert a
trophic influence on the arterial wall during early development (Lee
et al., 1987
; Mangiarua and Lee, 1992
), they help maintain vascular smooth muscle in a differentiated contractile state in the
adult (Bevan and Tsuru, 1981
; Branco et al., 1984
).
Similarly, the presence of sympathetic neurons delayed phenotypic
modulation and growth in primary smooth muscle cultures of pig vas
deferens and rabbit aorta and ear artery (Chamley et al.,
1974
, Chamley-Campbell et al., 1979
). This has been
suggested to be mediated by adenosine derived from neurogenically
released ATP (Osswald, 1991
). It may be worth addressing the
possibility that nervous influences on postjunctional pharmacological
properties may be rather nonselective in nature, i.e., not
limited to alpha-1A AR, but part of a general influence of
periarterial nerves on the phenotype of arterial smooth muscle cells.
Future analysis of mechanisms and functional significance should
ideally address expression, presence and efficacy of alpha-1
AR subtypes in the same tissues because possible discrepancies between
expression, density, distribution and coupling of membrane receptors
and differences between rat strains (Stassen et al., 1997
).
In conclusion, we confirmed that rat arteries are innervated to a
different extent by adrenergic nerves. Furthermore, the presence of the
alpha-1A AR subtype seems to be positively related to the
arterial innervation. Our findings indicate that this relationship is
dynamic in nature and may involve a high neurogenic input because removal of the adrenergic nerves substantially changed the
alpha-1 AR subtype composition in densely innervated
arteries. This may be important in pathophysiological situations
characterized by an increased sympathetic activity, such as
hypertension (Lee et al., 1983
; Mangiarua and Lee, 1990
), or
by depletion of sympathetic nerves as in congestive heart failure
(Zelis et al., 1993
).
| |
Footnotes |
|---|
Accepted for publication September 26, 1997.
Received for publication February 7, 1997.
1 This work was supported by grant 902-18-291 PGN of the Netherlands Scientific Research Organization (NWO) and the Netherlands Heart Foundation (NHS) and by the EU-sponsored BIOMED1 initiatives EURAD and EURECA.
Send reprint requests to: Dr. Jo G. R. De Mey, Ph.D., Dept. of Pharmacology, Universiteit Maastricht, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
| |
Abbreviations |
|---|
alpha-1 AR, alpha-1
adrenoceptor;
CEC, chloroethylclonidine;
NE, norepinephrine;
KRB, Krebs-Ringer bicarbonate buffer;
SM
-actin, smooth muscle
-actin;
RT, reverse transcriptase;
PCR, polymerase chain reaction;
bp, base
pairs.
| |
References |
|---|
|
|
|---|
1A-adrenoceptors in rat kidney.
Br J Pharmacol
107: 414-417[Medline].
-adrenoceptor-mediated responses in rat isolated vascular tissues.
J Pharmacol Exp Ther
245: 673-681
1A-adrenoceptor of rat and the cloned bovine
1C-adrenoceptor: A revised
1-adrenoceptor classification scheme.
Pharm Comm
6: 9-14.
1-adrenergic receptor subtypes in continuous cell lines.
Pharmacol Commun
6: 39-45.
-adrenoceptors on arteriolar and venular smooth muscle in rat skeletal muscle microcirculation.
Circ Res
62: 37-50
1-adrenoceptor classification: sharpening Occam's razor.
Trends Pharmacol Sci
15: 167-170[Medline].
1-adrenergic receptor subtypes. Molecular structure, function and signaling.
Circ Res
78: 737-749
1-adrenergic receptor binding sites in rat tissues.
J Pharmacol Exp Ther
40: 531-538.
1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists.
Br J Pharmacol
97: 691-700[Medline].
1a- and
1b-adrenoceptor binding sites: evidence for a subtype-specific regulation.
Br J Clin Pharmacol
30: 125S-127S.
1-Adrenoceptors: the ability of various agonists and antagonist to discriminate between two distinct [3H]prazosin binding sites.
J Pharm Pharmacol
41: 714-716[Medline].
1-adrenoceptors: Concensus update.
Pharmacol Rev
47: 267-270[Medline].
1-adrenergic receptor subtypes in established hypertension.
J Cardiovasc Pharmacol
19: 857-862[Medline].
1C-adrenergic receptor shows the pharmacological properties of the classical
1A subtype.
Mol Pharmacol
46: 414-422[Abstract].
1-adrenergic receptor subtype mRNAs and inhibits
-adrenergic receptor-stimulated cardiac hypertrophy and signaling.
Circulation
92: 918-925
1B- but not
1A-adrenoceptors mediate inositol phosphate generation.
Naunyn-Schmiedeberg's Arch Pharmacol
341: 385-387[Medline].
1-adrenoceptor subtypes.
Naunyn-Schmiedeberg's Arch Pharmacol
350: 136-142[Medline].
1-adrenoceptors in vascular smooth muscle.
Br J Pharmacol
99: 197-201[Medline].
1-adrenoceptor subtype involved in the positive inotropic response to phenylephrine in rat aorta.
Eur J Pharmacol
240: 291-293[Medline].
1- and
2-adrenoceptors on microvascular smooth muscle during sympathetic nerve stimulation.
Circ Res
68: 232-244
1-adrenoceptor.
Eur J Pharmacol
199: 279-289[Medline].
1D-adrenoceptor and two other
1-adrenoceptors in vascular smooth muscle.
Mol Pharmacol
46: 30-40[Abstract].
1-adrenergic receptor subtype mRNA are differentially regulated by
1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. Repression of
1B and
1D but induction of
1C.
J Biol Chem
271: 5839-5843
1-adrenoceptor subtypes in rat aorta and mesenteric small arteries are preserved during left ventricular dysfunction post myocardial infarction.
Cardiovasc Res
33: 706-713
1-adrenoceptors mediating vasoconstriction to noradrenaline and nerve stimulation in the isolated perfused mesentery of rat.
Br J Pharmacol
114: 531-536[Medline]. This article has been cited by other articles:
![]() |
D. H. Damon TH and NPY in sympathetic neurovascular cultures: role of LIF and NT-3 Am J Physiol Cell Physiol, January 1, 2008; 294(1): C306 - C312. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Damon, J. A. teRiele, and S. B. Marko Vascular-derived artemin: a determinant of vascular sympathetic innervation? Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H266 - H273. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Daly, C. Deighan, A. McGee, D. Mennie, Z. Ali, M. McBride, and J. C. McGrath A knockout approach indicates a minor vasoconstrictor role for vascular {alpha}1B-adrenoceptors in mouse Physiol Genomics, May 10, 2002; 9(2): 85 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ruijtenbeek, F. A. C. le Noble, G. M. J. Janssen, C. G. A. Kessels, G. E. Fazzi, C. E. Blanco, and J. G. R. De Mey Chronic Hypoxia Stimulates Periarterial Sympathetic Nerve Development in Chicken Embryo Circulation, December 5, 2000; 102(23): 2892 - 2897. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Steinmetz, E. Schlatter, H. A. J. S. Boudier, K. H. Rahn, and J. G. R. De Mey Diadenosine Polyphosphates Cause Contraction and Relaxation in Isolated Rat Resistance Arteries J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1175 - 1181. [Abstract] [Full Text] |
||||
![]() |
F. A. C. le Noble, K. Ruijtenbeek, S. Gommers, J. G. R. de Mey, and C. E. Blanco Contractile and relaxing reactivity in carotid and femoral arteries of chicken embryos Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1261 - H1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Buus, F. Pourageaud, G. E. Fazzi, G. Janssen, M. J. Mulvany, and J. G.R. De Mey Smooth Muscle Cell Changes During Flow-Related Remodeling of Rat Mesenteric Resistance Arteries Circ. Res., July 20, 2001; 89(2): 180 - 186. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||